Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Phospholamban anticorps (N-Term)

Cet anticorps anti-Phospholamban est un anticorps Lapin Polyclonal détectant Phospholamban dans WB. Adapté pour Humain. Ce Primary Antibody a été cité dans 4+ publications.
N° du produit ABIN1882182

Aperçu rapide pour Phospholamban anticorps (N-Term) (ABIN1882182)

Antigène

Voir toutes Phospholamban (PLN) Anticorps
Phospholamban (PLN)

Reactivité

  • 83
  • 23
  • 22
  • 3
  • 2
  • 2
  • 2
Humain

Hôte

  • 84
  • 2
  • 1
Lapin

Clonalité

  • 83
  • 4
Polyclonal

Conjugué

  • 40
  • 6
  • 5
  • 5
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
Cet anticorp Phospholamban est non-conjugé

Application

  • 36
  • 31
  • 26
  • 26
  • 18
  • 10
  • 9
  • 9
  • 8
  • 7
  • 6
  • 6
  • 1
  • 1
Western Blotting (WB)

Clone

RB44799
  • Épitope

    • 26
    • 17
    • 12
    • 9
    • 7
    • 6
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1-22, N-Term

    Homologie

    B, M, Pig, Rb, Rat

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogène

    This PLN antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 1-22 amino acids from the N-terminal region of human PLN.

    Isotype

    Ig Fraction
  • Indications d'application

    WB: 1:1000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C,-20 °C

    Date de péremption

    6 months
  • Kaliman, Catalucci, Lam, Kondo, Gutiérrez, Reddy, Palacín, Zorzano, Chien, Ruiz-Lozano: "Myotonic dystrophy protein kinase phosphorylates phospholamban and regulates calcium uptake in cardiomyocyte sarcoplasmic reticulum." dans: The Journal of biological chemistry, Vol. 280, Issue 9, pp. 8016-21, (2005) (PubMed).

    Minamisawa, Sato, Tatsuguchi, Fujino, Imamura, Uetsuka, Nakazawa, Matsuoka: "Mutation of the phospholamban promoter associated with hypertrophic cardiomyopathy." dans: Biochemical and biophysical research communications, Vol. 304, Issue 1, pp. 1-4, (2003) (PubMed).

    McTiernan, Frye, Lemster, Kinder, Ogletree-Hughes, Moravec, Feldman: "The human phospholamban gene: structure and expression." dans: Journal of molecular and cellular cardiology, Vol. 31, Issue 3, pp. 679-92, (1999) (PubMed).

    Fujii, Zarain-Herzberg, Willard, Tada, MacLennan: "Structure of the rabbit phospholamban gene, cloning of the human cDNA, and assignment of the gene to human chromosome 6." dans: The Journal of biological chemistry, Vol. 266, Issue 18, pp. 11669-75, (1991) (PubMed).

  • Antigène

    Phospholamban (PLN)

    Autre désignation

    PLN

    Sujet

    Reversibly inhibits the activity of ATP2A2 in cardiac sarcoplasmic reticulum by decreasing the apparent affinity of the ATPase for Ca(2+). Modulates the contractility of the heart muscle in response to physiological stimuli via its effects on ATP2A2 Modulates calcium re-uptake during muscle relaxation and plays an important role in calcium homeostasis in the heart muscle. The degree of ATP2A2 inhibition depends on the oligomeric state of PLN. ATP2A2 inhibition is alleviated by PLN phosphorylation.

    Poids moléculaire

    6109

    UniProt

    P26678

    Pathways

    Negative Regulation of Transporter Activity
Vous êtes ici:
Chat with us!